COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,397 Articles (22,816 medRxiv, 8,581 bioRxiv)

Most recent first Previous |  Page 1608: Articles 16071-16080  | Next

Modelling to inform the COVID-19 response in Bangladesh
Ferguson, E. A., Brum, E., Chowdhury, A., Chowdhury, S., Kundegorski, M., Mahmud, A. S., Purno, N., Sania, A., Steenson, R., Tasneem, M., Hampson, K.
10.1101/2021.04.19.21255673 — Posted: 2021-04-22
Effects of BNT162b2 mRNA vaccine on Covid-19 infection and hospitalisation among older people: matched case control study for England
Mason, T. F. D., Whitston, M., Hodgson, J., Watkinson, R. E., Lau, Y.-S., Abdulrazeg, O., Sutton, M.
10.1101/2021.04.19.21255461 — Posted: 2021-04-22
Patient symptoms and experience following COVID-19: results from a UK wide survey
Buttery, S. C., Philip, K. E. J., Williams, P. J., Fallas, A., West, B., Cumella, A., Cheung, C., Walker, S., Quint, J. K., Polkey, M. I., Hopkinson, N. S.
10.1101/2021.04.15.21255348 — Posted: 2021-04-22
Understanding the barriers to pooled SARS-CoV-2 testing in the United States
Fenichel, E. P., Gilbert, A., Gonsalves, G. S., Wyllie, A. L.
10.1101/2021.04.17.21255440 — Posted: 2021-04-22
COVID-19 risk assessment for the Tokyo Olympic Games
Zhu, W., Feng, J., Li, C., Wang, H., Zhong, Y., Zhang, X., Zhang, T.
10.1101/2021.04.14.21255261 — Posted: 2021-04-22
Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618,161 people in primary care
Carr, M. J., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., Rutter, M. K.
10.1101/2021.04.21.21255869 — Posted: 2021-04-22
Mid-Regional pro-Adrenomedullin (MR-proADM), C-Reactive Protein (CRP) and Other Biomarkers in the Early Identification of Disease Progression in COVID-19 Patients in the Acute NHS Setting
Moore, N. A., Williams, R., Mori, M., Bertolusso, B., Vernet, G., Lynch, J., Philipson, P., Ledgerwood, T., Kidd, S. P., Thomas, C., Garcia-Arias, V., Young, M., Saeed, K., Gordon, K., Cortes, N.
10.1101/2021.04.19.21252978 — Posted: 2021-04-22
Association of in-hospital use of ACE-I/ARB and COVID-19 outcomes in African American population
Li, S., Sarangarajan, R., Jun, T., Kao, Y.-H., Wang, Z., Schadt, E., Kiebish, M. A., Granger, E., Narain, N. R., Chen, R., Schadt, E. E., Li, L.
10.1101/2021.04.14.21255443 — Posted: 2021-04-22
Previous COVID-19 infection but not Long-COVID is associated with increased adverse events following BNT162b2/Pfizer vaccination
Raw, R. K., Kelly, C., Rees, J., Wroe, C., Chadwick, D. R.
10.1101/2021.04.15.21252192 — Posted: 2021-04-22
Post-vaccination SARS-CoV-2 infections and incidence of the B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center
Jacobson, K. B., Pinsky, B., Montez Rath, M. E., Wang, H., Miller, J. A., Skhiri, M., Shepard, J., Mathew, R., Lee, G., Bohman, B., Parsonnet, J., Holubar, M.
10.1101/2021.04.14.21255431 — Posted: 2021-04-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).